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ABSTRACT
The nucleotide sequence of black beetle virion (BBV) RNA2 has been
determined. RNA2 is 1399 b long. Its 5' terminus is capped. Its 3' terminus
has an unidentified moiety that renders the RNA resistent to polyadenylation
and ligation. The first AUG codon at base 23 is followed by an open reading
frame for a protein 407 amino acids long, the predicted size of coat protein
precursor. A second open reading frame for a putative protein 72 amino acid
residues long begins at base 1110. No other large open reading frames exist.
The 5' half of the RNA can be folded into a long, imperfect hairpin of high
predicted stability. The 3' half of the RNA can fold into a ccxmplex set of
multiply bifurcated stem and loop regions.
INTRODUCTION
BBV (black beetle virus) is a member of the family Nodaviridae (1). Its
genome consists of two messenger-sense RNAs (2). Virion RNA1 (22S) serves as
the genome and the messenger for protein A (m.w. 104 kD), involved in viral
RNA replication (3). The 3' terminal region of RNA1 also encodes the sequence
of RNA3 (9S) found in infected cells but not in virions. RNA3 is the
messenger for protein B (m.w. 10 kD) involved in the regulation of
translation of protein A (4). Virion RNA2 (15S) is the genane and the
messenger for protein alpha (m.w. 47 kD) which is proteolytically processed
to give viral coat pi-otein. RNA2 also exerts a regulatory function on the
production of RNA3 (3). RNA1 can replicate independently of RNA2 and its gene
product protein B (3). Crystals of BBV have been obtained and their analysis
is underway (5).
We undertook nucleotide sequence analysis of the BBV RNAs to search for
signals for RNA encapsidation, RNA replication and other functions crucial for
viral infectivity. In this report, we present the sequence of BBV RNA2 and
thereby the primary structure of the encoded virion coat protein and examine
other features suggested by the sequence.
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MATERIALS AND METHODS
Enzymes and isotopes required for direct RNA sequencing were as described
(6-8). Other sources were as follows: reverse transcriptase (Life Sciences,
Inc.); tobacco acid pyrophosphatase, E. coli poly A polymerase and vaccinia
guanylyl transferase (B.R.L.); restriction enzymes (New England Biolabs,
Biotec or B.R.L.); oligodeoxynucleotides (P-L Biochemicals); (gamma-32P)ATP,
(5000 Ci/mmole), (alpha-32P)ATP, (alpha-32P)GTP and (alpha-32P)dATP (400-800
Ci/mmole) and (5'-32P)pCp (3000 Ci/m mole), (Amersham) . Low melting point
agarose was from B.R.L.
Virion RNA2 was isolated as described (9). dsRNAs were isolated from BBV
infected Drosophila cells by the LiCl precipitation method (10) and were
purified in either 1.5% low melting point agarose gels or 6% polyacrylamide
gels in Tris-EDTA-Borate buffer, pH 8.3.
Intact RNA2 was labeled at its 5' end with guanylyl transferase (11) after
chemical decapping (12) and with polynucleotide kinase (6) after chemical or
enzymatic decapping and phosphatase treatment (13).
Purified dsRNA2 was labeled at its 3' end with 32pCp and T4 RNA ligase
(14). Positive and negative strands were separated on 5% polyacrylamide gels
with low cross-linking (8). RNA fragments, obtained after complete RNase A
digestion (15) or partial Ti ribonuclease digestion (6), were labeled at their
3' ends with pCp and T4 RNA ligase and were fractionated on 10% or 20%
urea-polyacrylamide gels (8).
End labeled RNAs were sequenced by enzymatic cleavage methods (6,16) and
also by the chemical method (17).
Single stranded BBV2 cDNA was prepared by random priming with partially
digested calf thymus DNA as described by Taylor et al. (18). Actinomycin D
(40 ug/ml) was used to prevent double stranded DNA formation. The cDNAs were
fragmented with restriction enzymes HaeIII, AluI, TaqI, HpaII and HhaI all of
which recognize ss DNA (19,20).
Double stranded cDNA was prepared from ss cDNA and cloned into pBR322 as
described (21). The cDNA inserts were separated from pBR322 sequences by PstI
digestion and gel electrophoresis. Fragments were prepared by digestion with
suitable restriction enzymes, phosphatase treatment, polynucleotide kinase
labeling, and strand separation (8,22).
Such DNA, above, was sequenced by the chemical method (8).
RESULTS AND DISCUSSION
The sequence of BBV RNA2 is given in Fig. 1.
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Fig. 1. Nucleotide sequence of BBV RNA2 and the encoded amino acid
sequence of the viral coat protein precursor. Asterisks show the
termination codons for the two open reading frames.
5' Terminal Structure and Direct RNA sequencing
BBV RNA2 could be labeled at the 5' end only after chemical or enzymatic
treatment appropriate for removing a capped structure. Attempts to label
after alkaline phosphatase treatment alone were not successful. Analysis of
uniformly labeled RNA2 by enzymatic digestion and paper electrophoresis showed
the capped structure to be m7GpppGp.
In preliminary studies of 5' labeled RNA the sequence of the first 10
5'-proximal bases was determined by mobility shift analysis with two
dimensional paper electrophoresis and homochromatography (23).
The first 400 bases were determined by enzymatic sequencing on gels (16).
cDNA Sequencing
All but the 67 3' terminal bases were determined by chemical sequencing of
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Fig. 2. Schematic diagram summarizing the BBV RNA2 sequence data. The
scale at the top indicates the nucleotide position. The arrows, which
are aligned with the scale, show the direction and extent of the sequence
determined in each experiment. HaeIII, TaqI, HhaI and HpaII indicate ss
cDNA fragments generated by the respective restriction enzymes. PB36 is
a cDNA clone used to determine sequences in both directions. All DNA
sequencing was done by the chemical method of Maxam and Gilbert. RNA(E)
indicates 5'-labeled RNA2 sequenced by the enzymatic method. dsRNA(E)
and dsRNA(C) indicate the positive strand of 3'-labeled dsRNA2 sequenced
by enzymatic and chemical methods respectively.
restriction fragments of cDNA (See Fig. 2) that had been synthesized with
reverse transciptase with partially digested calf thymus DNA serving as a
primer (18). We avoided cloning procedures which might arbitrarily select a
particular sequence in the event of heterogeneity.
We were unsuccessful in polyadenylating the 3' terminus of virion-derived
RNA2 which would have allowed primed cDtNA synthesis to begin there. We used
standard (24) as well as denaturing conditions e.g. prior heating to 100 c,
prior treatment with phosphatase, reaction at low ionic strength, and addition
of DMSO. Such virion-derived RNA2 also resisted enzymatic addition of pCp
which would have permitted use of direct RNA sequencing procedures.
Sequencing of the 3' terminal Regions of dsRNA2
Double stranded RNA2, isolated from infected cells, accepted both adenylate
and pCp under standard conditions with poly A polermerase and T4 RNA ligase,
respectively. Thus dsRNA2 was labeled with pCp at its 3' termini, the strands
were separated on a 5% nondenaturing gel (8). and the sequence of the 200 3'
terminal bases of each were determined. The sequence at the 3' end of
positive strand agreed with the sequence of ssRNA2 already determined and
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extended it to its terminus. The sequence at the 3' end of the negative
strand was identical to the compliment of the sequence at the 5' end of ssRNA,
indicating that dsRNA2 indeed contains a full length copy of virion RNA.
In order to obtain additional structural information about the RNA2 3'
terminus, a complete RNase A digest of the plus strand of dsRNA2 was treated
with ligase in the presence of p32pCp. Only the original terminus should
contribute an hydroxyl group available for labeling. Subsequent fractionation
yielded a labeled hexamer whose sequence we determined to be ApApGpGpUpCp in
agreement with the determined 3' terminal sequence. Single stranded RNA2,
derived from virions, was treated similarly. There was no significant
labeling of any of the products of the RNase A digestion. Because short RNA
fragments are unable to make base pairs within themselves these results
suggest that vir ion RNA2 has a 3' terminal structural feature other than
secondary structure that prevents pCp or adenylate addition.
Sequencing of Cloned cDNA
Although the sequence determinations described above were completely
unambiguous, it was possible that a sequencing band might be obscured by the
existence of a strong secondary structure feature. To minimize this chance
for error we examined sequences of the negative strands of some cDNA clones
that had been prepared for use as probes in experiments unrelated to this
report. In particular a clone comprised of the first 800 bases from the 5'
end BB2 DNA was sequenced in both directions after fragmentation with
restriction enzymes HaeIII, DDEI, Sau3A and Sau96. This, and all of our other
sequence determinations of cDNA clones, completely confirmed our original
analyses.
Features of the Sequence
The first AUG codon for BBV RNA2 is 23 bases from the 5' end. Consistent
with the eukaryotic ribosome binding model of Kozak (25), the third prior base
is A and a G immediately follows the AUG. The leader sequence is markedly
rich (45%) in A. The open reading frame following the initial AUG extends to
base 1243 (i.e. 156 bases from the 3' terminus, Fig. 3) encoding for 407
amino acid residues in good agreementh with electrophoretic determinations of
the size of coat protein precursor. A second open reading frame extends from
base 1110 to 1325 (74 bases from the 3' terminus) coding for a putative
protein 72 amino acid residues in length. There is a long open reading frame,
corresponding to a protein of 267 amino acid residues in the negative strand
(Fig. 3). The codon usage in BBV coat protein shows a slight preference for
U in the third position. There are five cysteine residues, all coded by UGU.
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Fig. 3. Map of BBV RNA2 showing open reading frames. The top three
lines show the possible reading frames in the virion RNA and the bottom
three lines show the same in the complementary strand. The marks above
the lines indicate positions of AUG codons, the marks below the lines
indicated positions of UGA, UAG or UAA codons. The cistron for coat
protein precursor alpha is shown by the solid arrow. Others are shown by
open arrows.
The amino acid sequence of coat protein precursor (Fig. 1) shows that the
N-terminal structure is very rich in basic amino acids. Sixteen amino acids
out of first 50 are arginine. There are 27 arginines in the coat protein.
Also, asparagines, threonines and arginine appear in a row towards the
N-terminus. This gives this end of coat protein a distinctive structure
similar to that existing with plant viruses (26-29) where it is thought to be
involved in the protein-RNA interaction necessary for encapsidation.
Identical stretches of 6 bases (bases 9-14 and bases 16-21) and 8 bases
(bases 33-40 and bases 71-78) exist near the 5' end of RNA2.
We observed some evidence of sequence heterogeneity. Position 627 showed a
minor band due to A in chemical cDNA sequencing. Also, in enzymatic RNA
sequencing, position 1394 showed a minor band due to A and positions 1395 and
1396 showed minor bands due to G.
Secondary Structure
Various computer programs have been devised for predicting RNA secondary
structure given the base sequence and assuming particular values for the
strength of hydrogen bonding, stacking and other interactions. Among these
the method of Zuker and Stiegler (30) has reproduced for viroid RNA and
ribosomal RNA, the secondary structures that had already been derived on the
basis of a variety of physical, enzymological and geneological evidence.
Application of the Zuker and Stiegler program to RNA2 gave a complicated
melange of stems and loops that suggest that BBV RNA2 has a remarkably stable
and distinctive secondary stucture in solution. As shown in Fig. 4, the 3'
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half of the RNA can fold into a single, long, imperfect hairpin that has
several short stem and loop regions and a large (200 bases long) multiply
bifurcated set of stems and loops projecting from its side, the base of the
hairpin being stabilized by an exceptionally long (38 bases) helix. The 5'
half can fold into an intricate, multiply bifurcated structure also of high
predicted stablility.
We have systematically analyzed other possible folding by examination of
so-called dot patterns which match all G-C, G-U and A-U base pairs and
graphically display those contiguous pairs of a specified minimum length or
pairing strength. We conclude that almost all of the strongly base paired
regions of Fig. 4 that isolate small loop regions, persist over a range of
choices of energy parameters (such parameters as energy gained for particular
base pairs and energy lost by looping out of particular bases) and are likely
to exist in neutral solutions (e.g. bases 900-924). However base pairings in
Fig. 4 between regions whose sequnce separation is large (even e.g. such sets
as bases 709-727 vs. 1390-1372) are not strongly favored over markedly
different base pairing choices.
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